1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunoassays
1.2.3 Flow Cytometry
1.2.4 Rapid Tests
1.2.5 Molecular Assays
1.2.6 Tissue Arrays
1.2.7 Circulating Tumor Cells
1.2.8 Pharmacodiagnostics
1.2.9 Biomarkers
1.2.10 Other Diagnostics Methods
1.3 Market by Application
1.3.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Precision Medicine
1.3.3 Personalized Medicine
1.3.4 Cancer Monitoring
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2017-2028)
2.2 Lung Cancer Diagnostic Tests Growth Trends by Region
2.2.1 Lung Cancer Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lung Cancer Diagnostic Tests Historic Market Size by Region (2017-2022)
2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028)
2.3 Lung Cancer Diagnostic Tests Market Dynamics
2.3.1 Lung Cancer Diagnostic Tests Industry Trends
2.3.2 Lung Cancer Diagnostic Tests Market Drivers
2.3.3 Lung Cancer Diagnostic Tests Market Challenges
2.3.4 Lung Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2017-2022)
3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2017-2022)
3.2 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue
3.4 Global Lung Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2021
3.5 Lung Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Lung Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Lung Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2017-2022)
4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028)
5 Lung Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Application (2017-2022)
5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lung Cancer Diagnostic Tests Market Size (2017-2028)
6.2 North America Lung Cancer Diagnostic Tests Market Size by Type
6.2.1 North America Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)
6.2.2 North America Lung Cancer Diagnostic Tests Market Size by Type (2023-2028)
6.2.3 North America Lung Cancer Diagnostic Tests Market Share by Type (2017-2028)
6.3 North America Lung Cancer Diagnostic Tests Market Size by Application
6.3.1 North America Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)
6.3.2 North America Lung Cancer Diagnostic Tests Market Size by Application (2023-2028)
6.3.3 North America Lung Cancer Diagnostic Tests Market Share by Application (2017-2028)
6.4 North America Lung Cancer Diagnostic Tests Market Size by Country
6.4.1 North America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
6.4.2 North America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Lung Cancer Diagnostic Tests Market Size (2017-2028)
7.2 Europe Lung Cancer Diagnostic Tests Market Size by Type
7.2.1 Europe Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)
7.2.2 Europe Lung Cancer Diagnostic Tests Market Size by Type (2023-2028)
7.2.3 Europe Lung Cancer Diagnostic Tests Market Share by Type (2017-2028)
7.3 Europe Lung Cancer Diagnostic Tests Market Size by Application
7.3.1 Europe Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)
7.3.2 Europe Lung Cancer Diagnostic Tests Market Size by Application (2023-2028)
7.3.3 Europe Lung Cancer Diagnostic Tests Market Share by Application (2017-2028)
7.4 Europe Lung Cancer Diagnostic Tests Market Size by Country
7.4.1 Europe Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
7.4.2 Europe Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (2017-2028)
8.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Type (2017-2028)
8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Application (2017-2028)
8.4 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lung Cancer Diagnostic Tests Market Size (2017-2028)
9.2 Latin America Lung Cancer Diagnostic Tests Market Size by Type
9.2.1 Latin America Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)
9.2.2 Latin America Lung Cancer Diagnostic Tests Market Size by Type (2023-2028)
9.2.3 Latin America Lung Cancer Diagnostic Tests Market Share by Type (2017-2028)
9.3 Latin America Lung Cancer Diagnostic Tests Market Size by Application
9.3.1 Latin America Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)
9.3.2 Latin America Lung Cancer Diagnostic Tests Market Size by Application (2023-2028)
9.3.3 Latin America Lung Cancer Diagnostic Tests Market Share by Application (2017-2028)
9.4 Latin America Lung Cancer Diagnostic Tests Market Size by Country
9.4.1 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
9.4.2 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size (2017-2028)
10.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Type (2017-2028)
10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Application (2017-2028)
10.4 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advpharma Inc
11.1.1 Advpharma Inc Company Details
11.1.2 Advpharma Inc Business Overview
11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction
11.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.1.5 Advpharma Inc Recent Developments
11.2 AIT Austrian Institute of Technology GmbH
11.2.1 AIT Austrian Institute of Technology GmbH Company Details
11.2.2 AIT Austrian Institute of Technology GmbH Business Overview
11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction
11.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.2.5 AIT Austrian Institute of Technology GmbH Recent Developments
11.3 Courtagen Life Sciences Inc
11.3.1 Courtagen Life Sciences Inc Company Details
11.3.2 Courtagen Life Sciences Inc Business Overview
11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction
11.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.3.5 Courtagen Life Sciences Inc Recent Developments
11.4 DiagnoCure Inc. (Inactive)
11.4.1 DiagnoCure Inc. (Inactive) Company Details
11.4.2 DiagnoCure Inc. (Inactive) Business Overview
11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction
11.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.4.5 DiagnoCure Inc. (Inactive) Recent Developments
11.5 BioMark Diagnostics Inc.
11.5.1 BioMark Diagnostics Inc. Company Details
11.5.2 BioMark Diagnostics Inc. Business Overview
11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction
11.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.5.5 BioMark Diagnostics Inc. Recent Developments
11.6 BioMarker Strategies LLC
11.6.1 BioMarker Strategies LLC Company Details
11.6.2 BioMarker Strategies LLC Business Overview
11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction
11.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.6.5 BioMarker Strategies LLC Recent Developments
11.7 Emory University
11.7.1 Emory University Company Details
11.7.2 Emory University Business Overview
11.7.3 Emory University Lung Cancer Diagnostic Tests Introduction
11.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.7.5 Emory University Recent Developments
11.8 Epigenomics AG
11.8.1 Epigenomics AG Company Details
11.8.2 Epigenomics AG Business Overview
11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction
11.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.8.5 Epigenomics AG Recent Developments
11.9 GlycoZym
11.9.1 GlycoZym Company Details
11.9.2 GlycoZym Business Overview
11.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction
11.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.9.5 GlycoZym Recent Developments
11.10 HalioDx SAS
11.10.1 HalioDx SAS Company Details
11.10.2 HalioDx SAS Business Overview
11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction
11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.10.5 HalioDx SAS Recent Developments
11.11 Louisville Bioscience, Inc.
11.11.1 Louisville Bioscience, Inc. Company Details
11.11.2 Louisville Bioscience, Inc. Business Overview
11.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction
11.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.11.5 Louisville Bioscience, Inc. Recent Developments
11.12 Mayo Clinic US
11.12.1 Mayo Clinic US Company Details
11.12.2 Mayo Clinic US Business Overview
11.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction
11.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2017-2022)
11.12.5 Mayo Clinic US Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
